0001752828 2025-01-01 2025-12-31 0001752828 2025-06-30 0001752828 2026-09-30 iso4217:USD shares iso4217:USD shares true FY 0001752828 10-K/A true 2025-12-31 --12-31 2025 false 001-38914 Celularity Inc. DE 83-1702591 170 Park Ave Florham Park NJ 07932 (908) 768-2170 Class A common stock, par value $0.0001 per share CELU NASDAQ No No Yes Yes Non-accelerated Filer true false false false false 28400000 32449891 0.0001 None Celularity Inc. is filing this Amendment No. 1 on Form 10-K/A (the “Amendment”) to amend its original Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “Original Form 10-K”), originally filed with the Securities and Exchange Commission (the “SEC”) on April 30, 2026, for the sole purpose of including the information required by Part III. This Amendment consists solely of the preceding cover page, this explanatory note, Part III, Items 10, 11, 12, 13 and 14, Part IV, Item 15 list of exhibits, the signature page and new certifications by the Company’s principal executive officer and principal financial officer are filed as exhibits (in Exhibits 31.1, 31.2, and 32.1) to this Amendment. Except as described above, this Amendment does not amend, update or change any other items or disclosures contained in the Original Form 10-K and except for the Part III information expressly included in this Amendment, does not reflect or purport to reflect any information or events occurring after the original filing date or modify or update those disclosures affected by subsequent events. Accordingly, this Amendment should be read in conjunction with the Original Form 10-K and the Company’s other filings with the SEC.